Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy
There is a lack of FDA-approved tocolytics for the management of preterm labor (PL). In prior drug discovery efforts, we identified mundulone and mundulone acetate (MA) as inhibitors of in vitro intracellular Ca2+-regulated myometrial contractility. In this study, we probed the tocolytic potential o...
Saved in:
Main Authors: | Shajila Siricilla (Author), Christopher J. Hansen (Author), Jackson H. Rogers (Author), Debasmita De (Author), Carolyn L. Simpson (Author), Alex G. Waterson (Author), Gary A. Sulikowski (Author), Stacey L. Crockett (Author), Naoko Boatwright (Author), Jeff Reese (Author), Bibhash C. Paria (Author), J. Newton (Author), Jennifer L. Herington (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
O atosibano como agente tocolítico: uma nova proposta de esquema terapêutico Atosiban as a tocolytic agent: a new proposal of a therapeutic approach
by: Fábio Roberto Cabar, et al.
Published: (2008) -
Management of preterm labor: atosiban or nifedipine?
by: Roel de Heus, et al.
Published: (2010) -
Modern tocolysis and adverse effects of tocolytics
by: O R Baev, et al.
Published: (2018) -
Critical appraisal and clinical utility of atosiban in the management of preterm labor
by: Olaleye Sanu, et al.
Published: (2010) -
Pregnancy-Related Stress Among Pregnant Women Receiving Tocolytic and Non-Tocolytic Treatments Where Both Used Complementary Medicine
by: Chen-Yuan Hsu, et al.
Published: (2022)